• Choanal atresia: therapeu...
Price 10.50 €
• Usefulness and limitation...
Price 10.50 €
• Pyogenic granuloma of the...
Price 8.50 €
• Petrosal presigmoid appro...
Price 8.50 €
• Middle ear tuberculosis e...
Price 5.50 €
• Acoustic study of sustain...
Price 10.50 €
• Adenoid cystic carcinoma ...
Price 5.50 €
• The lymphoepithelial carc...
Price 5.50 €
• A single appointment with...
Price 8.50 €
• Botulinum toxin, descript...
Price 12.50 €
• Non-functioning parathyro...
Price 5.50 €
• Extramuscular soft tissue...
Price 8.50 €
• Nasal involvement in Croh...
Price 10.50 €
• These lesions of the voca...
Price 10.50 €
• Hearing aid : practical a...
Price 8.50 €
• Evaluation of the handica...
Price 10.50 €
• Reconstruction after tumo...
Price 10.50 €
• Chyle leak after cervical...
Price 15.00 €
• Liposarcoma of the hypoph...
Price 5.50 €
• From barotrauma otitis to...
Price 8.50 €
• Covering of parotid and c...
Price 14.00 €
• Late metastasis from rena...
Price 8.50 €
• Endoscopic anatomy of the...
Price 10.50 €
• Cleft palate and otitis m...
Price 10.50 €
• Middle ear osteoma: A rar...
Price 8.50 €
• Management of cervical ly...
Price 10.50 €
• Prognostic value of senti...
Price 10.50 €
• Interest of the chest CT ...
Price 10.50 €
• Parry-Romberg syndrome as...
Price 12.50 €
• Congenital absence of the...
Price 8.50 €
• Therapeutic choices for c...
Price 8.50 €
• Adenoid cystic carcinoma ...
Price 5.50 €
• Dysphonia in children: Re...
Price 12.50 €
• The complications of end...
Price 8.50 €
• Nasal cutaneous cryptococ...
Price 5.50 €
Total Order 324.50 €
|
2019
N#
1
|
2018
N#
1
|
2
|
3
|
4
|
5
|
2017
N#
1
|
2
|
3
|
4
|
5
|
2016
N#
1
|
2
|
3
|
4
|
5
|
2015
N#
1
|
2
|
3
|
4
|
5
|
2014
N#
1
|
2
|
3
|
4
|
5
|
2013
N#
1
|
2
|
3
|
4
|
5
|
2012
N#
1
|
2
|
3
|
4
|
5
|
2011
N#
1
|
2
|
3
|
4
|
5
|
2010
N#
1
|
2
|
3
|
4
|
5
|
2009
N#
1
|
2
|
3
|
4
|
5
|
2008
N#
1
|
2
|
3
|
4
|
5
|
2007
N#
1
|
2
|
3
|
4
|
5
|
2006
N#
1
|
2
|
3
|
4
|
5
|
2005
N#
|
1
|
2
|
3
|
4
|
5
|
2004
N#
1
|
2
|
3
|
4
|
5
|
2003
N#
1
|
2
|
3
|
4
|
5
|
2002
N#
1
|
2
|
3
|
4
|
5
|
2001
N#
1
|
2
|
3
|
4
|
5
|
2000
N#
|
1
|
2
|
3
|
4
|
5
|
1999
N#
1
|
2
|
3
|
4
|
5
|
1998
N#
1
|
2
|
3
|
5
|
1997
N#
1
|
2
|
3
|
4
|
5
|
1996
N#
4
|
5
|
Click on the number of the review to see the content
|
|
List of all teaching bulletins CME.
|
|
Editor reading committee.
|
|
Select of books and press articles.
|
|
If you wish to adjust the size of the displayed characters, click in
the high menu on "Your account" and choose the desired size.
|
|
Issue N# 3 - 2012
HEAD AND NECK
Parapharyngeal tumours: Management and postoperatory results analysis
Authors : Bourget K, Joubert M, Delemazure AS, Durand N, Espitalier F, Malard O. (Nantes)
Ref. : Rev Laryngol Otol Rhinol. 2012;133,3:129-136.
Article published in french 
Downloadable PDF document french
Summary :
Objectives: Parapharyngeal space tumours are rare and mostly benign, and their access is difficult. The aim of the study was to define the optimal treatment of these tumours. Material and methods: Clinical retrospective study, with histological, treatment, prognosis analysis of the parapharyngeal space tumours occurred between 1994 and 2012 and the surgical approach considerations. Results: 35 patients were included with a male sex ratio predominance (51,43%, p= ns). The mean age of diagnosis was 49 years. The majority of tumours were benign (75,76%, p< 0,001). 54,5% originated from salivary gland with a majority of pleomorphic adenomas (42,42%). The second most frequent aetiology found was schwannoma (21,21%). 2 patients refused the treatment. Accidentally discovered were frequent (28,57%). In the symptomatic forms, dysphagia dominated (25,71%). Oropharyngeal (20%) and/or cervical (17,14%) mass were rare. A CT scan and a MR imaging were performed in 82,86% and 71,43% of the cases. A fine needle aspiration cytology was achieved in 10 cases with a positive predictive value of 60%. The cervical submandibular trans digastric approach was the most accomplished (40%). Other approaches were also used: Trans oral (25,71%), parotidectomy (14,71%), combined trans oral and cervical or parotidectomy (14,71%) and the cervical approached associated to a mandibulotomy (5,71%). A complementary treatment was proposed in 85,7% of the cases of malignant tumours. Post-operative complications were dominated by Horner’s syndrome (n= 3), a temporary facial palsy (n= 5), definitive (n= 1), a velar insufficiency (n= 1), persistent pain (n= 6). Conclusions: The presence of 25% of malignant tumours and 40% of pleomorphic adenomas require removal of parapharyngeal tumours, even if non symptomatic.
Price : 10.50 €
|
|
|
|
